Which has the lower trailing P/E, DVA or MEDP?

DVA has the lower trailing P/E: DVA trades at 24.15 and MEDP at 33.81. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DVA or MEDP?

Over the past five years, MEDP grew revenue faster — DVA at a 3.71% CAGR versus MEDP at 22.03%.

Is DVA or MEDP more profitable?

MEDP runs the higher net margin — DVA at 5.65% versus MEDP at 17.67%.

How have DVA and MEDP total returns compared?

Over the past 5 years, DVA delivered 11.96% and MEDP delivered 26.81% annualized total return. Past performance doesn't predict future results.

DaVita Inc. (DVA) vs Medpace Holdings, Inc. (MEDP)

A side-by-side comparison of DaVita Inc. and Medpace Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 1, 2026. Differences are shown without an overall score or investment verdict.

DVA

DaVita Inc.

$15.41B

$240.09HealthcareAt close: Jul 31, 2026, 4:00 PM ET

MEDP

Medpace Holdings, Inc.

$16.11B

$577.11HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

Total return — DVA vs MEDP

growth of $100 · dividends reinvested · last 10y

DVA +212.0%MEDP +1976.7%MEDP compounded faster

Log scale — wide-divergence pair

DVA MEDP

DVA vs MEDP: by the numbers

•MEDP is the larger company ($16.11B vs $15.41B market cap).
•DVA trades at the lower trailing earnings multiple (24.15 vs 33.81 P/E), one valuation lens rather than an overall verdict.
•MEDP converts more revenue to profit (17.67% vs 5.65% net margin).
•MEDP grew revenue faster over the past five years (22.03% vs 3.71% CAGR).

Metrics side by side

Valuation

Metric	DVA	MEDP
P/E ratio	24.15	33.81
Forward P/E	16.14	32.79
P/S ratio	1.20	5.97
P/B ratio	N/A	38.26
PEG ratio	2.93	1.82
EV / EBITDA	10.39	27.14
FCF yield	9.03%	4.42%

Profitability

Metric	DVA	MEDP
Gross margin	31.10%	28.76%
Operating margin	15.01%	20.97%
Net margin	5.65%	17.67%
ROE	-114.70%	113.29%
ROIC	10.58%	67.94%

Growth (annualized)

Metric	DVA	MEDP
Revenue CAGR (5Y)	3.71%	22.03%
EPS CAGR (5Y)	8.25%	30.90%
FCF CAGR (5Y)	6.13%	23.40%
Total return CAGR (5Y)	14.82%	26.81%

Frequently asked

Which has the lower trailing P/E, DVA or MEDP?: DVA has the lower trailing P/E: DVA trades at 24.15 and MEDP at 33.81. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DVA or MEDP?: Over the past five years, MEDP grew revenue faster — DVA at a 3.71% CAGR versus MEDP at 22.03%.
Is DVA or MEDP more profitable?: MEDP runs the higher net margin — DVA at 5.65% versus MEDP at 17.67%.
How have DVA and MEDP total returns compared?: Over the past 5 years, DVA delivered 11.96% and MEDP delivered 26.81% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DVA analysis Full MEDP analysis Interactive comparison tool

Dig into the metrics

DaVita P/E ratio Medpace P/E ratio DaVita dividend yield Medpace dividend yield DaVita ROE Medpace ROE DaVita operating margin Medpace operating margin DaVita revenue growth Medpace revenue growth DaVita free cash flow Medpace free cash flow

DaVita & Medpace appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 1, 2026.